Skip to main content
OpenTrials
Completed

NCT Number: NCT00879411

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Practical experience report (PER) investigating the effect of Micardis® on the average 24h blood pressure of therapy-naive and therapy-experienced patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year–95 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who have recently been diagnosed with hypertension
  • Patients whose current blood pressure treatment are inadequate and needs to be revised are suitable for inclusion.

Exclusion criteria

None (according to investigator)

Treatment and study plan

Micardis

Drug

Primary outcomes

  1. Efficacy (Change of Systolic Blood Pressure)

    Time frame: baseline to 8 weeks

    Change from baseline in 24h systolic blood pressure (BP) at week 8

  2. Efficacy (Change of Diastolic Blood Pressure)

    Time frame: baseline to 8 weeks

    Change from baseline in 24h diastolic blood pressure (BP) at week 8

Secondary outcomes

  1. Overall Tolerability Scale

    Time frame: 8 weeks

    Safety and tolerability of Micardis® in the treatment of patients with hypertension over 8 weeks, using 10 point Likert scale with worst score=1, best score=10

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

24h BP Under Micardis in Daily Practice

Important dates

Study start
2009
Primary completion
2010
First posted
Apr 10, 2009
Registry last updated
Mar 28, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.